<DOC>
	<DOCNO>NCT02590107</DOCNO>
	<brief_summary>This clinical trial study use early oral supplementation improve nutritional status participant undergo hematopoietic stem cell transplant . Impaired nutritional status participant undergo hematopoietic stem cell transplant link decreased outcome increase length hospital stay increase time engraftment ( important milestone transplant recovery ) . Early oral supplementation may increase nutritional status help promote positive outcome participant undergo transplant .</brief_summary>
	<brief_title>Early Oral Supplementation Improving Nutritional Status Patients Undergoing Hematopoietic Stem Cell Transplant</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine early oral supplementation improve nutritional status , decrease length hospital stay , shortens time engraftment hematopoietic stem cell transplant ( HSCT ) participant . SECONDARY OBJECTIVES : I. Serum albumin , serum 25-hydroxy vitamin D , degree mucositis , score National Cancer Institute 's Common Toxicity Criteria ( NCI-CTC ) , validate widely accept scale use rating mucositis . The purpose secondary aim observe potential correlation retrospective prospective group , well assess need future research base correlation . OUTLINE : Participants receive Boost Plus orally ( PO ) twice daily ( BID ) Pro-Stat 101 PO BID begin one week schedule HSCT continue hospital discharge . If participant tolerate Boost Plus Pro-Stat , receive milkshake PO daily ( QD ) alternative .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Undergoing autologous reduce intensity conditioning ( RIC ) allogeneic HSCT A serum albumin great equal 2.5 g/dL Able understand sign consent Patients malabsorption problem , ulcerative colitis , irritable bowel syndrome , Crohn 's disease , bowel surgery gastric bypass , celiac disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>